Differential expression of circulating miRNAs in Parkinson's disease patients: Potential early biomarker?

被引:0
|
作者
Sulaiman, Siti Aishah [1 ]
Muhsin, Nor Ilham Ainaa [1 ]
Arshad, Ahmad Rasyadan [1 ]
Nazarie, Wan Fahmi Wan Mohamad [1 ]
Jamal, Rahman [1 ]
Ibrahim, Norlinah Mohamed [2 ]
Murad, Nor Azian Abdul [1 ]
机构
[1] UKM Med Mol Biol Inst UMBI, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia UKM, Fac Med, Dept Med, Neurol Unit, Kuala Lumpur, Malaysia
关键词
Blood biomarker; miRNA; microarray; Parkinson's disease; early Onset; Late onset Parkinson disease; DOPAMINERGIC-NEURONS; AKT1; GENE; MICRORNAS; VEGF; ASSOCIATION; APOPTOSIS; PATHWAY; PROTEIN; GROWTH; AXIS;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background & Objective: Circulating microRNAs (miRNAs) expressions have been suggested as potential biomarkers for Parkinson's Disease (PD). Identification of early biomarkers for PD is important and crucial as PD symptoms occur at a late stage. Hence, these biomarkers could be used in molecular diagnosis for early detection. We therefore examined and compared the expression of circulating miRNAs between PD patients and controls. We also compared the miRNAs expression between early-onset PD (EOPD) and late-onset PD (LOPD). Methods: RNA was extracted from the plasma of EOPD (onset age <50 years; n=14), LOPD (onset age < 60 years; n=14) and healthy controls (n=11). The miRNAs expression was determined using the Affymetrix GeneChip microarray. Differential analysis was performed using the R software. Significantly differentiated miRNAs were subsequently analyzed for functional enrichment and biological pathway using the FtmRich v1.3 software based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. The Omics.net was used to determine the predicted target mRNAs of these miRNAs, and their interactions, based on the five most differentially expressed miRNAs. Results: In total, 273 miRNAs were upregulated in PD patients compared to controls. The most significant miRNAs were hsa-miR-301a-3p, 100-5p, 140-5p, 486-3p, 143-3p (fold change ranging from 11.2 - 32.0). A total of 140 circulating miRNAs were differentially expressed in EOPD compared to LOPD. Five of these miRNAs (one upregulated miRNA (hsa-miR-29b-3p) and four downregulated miRNAs (hsa-miR-297, 4462, 1909-5p and 346) belonged exclusively to the EOPD patients. The predicted gene targets of these miRNAs involved in dopaminergic synapse regulation, crucial to the pathogenesis of PD. Conclusion: Circulating miRNAs differ between PD patients and controls, and between EOPD and LOPD patients. A validation study with a larger and more diverse multi-ethnic population should be conducted to confirm our results.
引用
收藏
页码:319 / 329
页数:11
相关论文
共 50 条
  • [1] Circulating exosomal miRNAs as potential biomarkers of Parkinson's disease
    De Benedittis, Selene
    Manna, Ida
    Quattrone, Andrea
    Iaccino, Enrico
    Arabia, Gennarina
    Quattrone, Aldo
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 476 - 476
  • [2] Differential expression of gut miRNAs in idiopathic Parkinson's disease
    Kurz, Anna
    Kumar, Rohit
    Northoff, Bernd H.
    Wenk, Catharina
    Schirra, Joerg
    Donakonda, Sainitin
    Hoeglinger, Guenter U.
    Schwarz, Johannes
    Rozanski, Verena
    Huebner, Rainer
    Botzel, Kai
    Holdt, Lesca Miriam
    Koeglsperger, Thomas
    [J]. PARKINSONISM & RELATED DISORDERS, 2021, 88 : 46 - 50
  • [3] Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease
    Xie, Shishuai
    Niu, Wanxiang
    Xu, Feng
    Wang, Yuping
    Hu, Shanshan
    Niu, Chaoshi
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022, 132 (07) : 673 - 688
  • [4] Circulating miRNAs as potential molecular biomarker of early pregnancy in ewes
    Kose, M.
    Kaya, M. S.
    Kirbas, M.
    Dursun, S.
    Hitit, M.
    Alak, I.
    Atli, M. O.
    [J]. REPRODUCTION IN DOMESTIC ANIMALS, 2018, 53 : 152 - 152
  • [5] miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
    Mushtaq, Gohar
    Greig, Nigel H.
    Anwar, Firoz
    Zamzami, Mazin A.
    Choudhry, Hani
    Shaik, Munvar M.
    Tamargo, Ian A.
    Kamal, Mohammad A.
    [J]. MEDICINAL CHEMISTRY, 2016, 12 (03) : 217 - 225
  • [6] Circulating miRNAs as Diagnostic Biomarkers for Parkinson's Disease
    Roser, Anna-Elisa
    Gomes, Lucas Caldi
    Schuenemann, Jonas
    Maass, Fabian
    Lingor, Paul
    [J]. FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [7] Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology
    Oliveira, Sara R.
    Dionisio, Pedro A.
    Guedes, Leonor Correia
    Goncalves, Nilza
    Coelho, Miguel
    Rosa, Mario M.
    Amaral, Joana D.
    Ferreira, Joaquim J.
    Rodrigues, Cecilia M. P.
    [J]. BIOMOLECULES, 2020, 10 (06) : 1 - 13
  • [8] Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson's disease
    Yao, Y-F
    Qu, M-W
    Li, G-C
    Zhang, F-B
    Rui, H-C
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (16) : 5278 - 5283
  • [9] Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting
    Cristina, Marcia
    dos Santos, Teixeira
    Bell, Rosie
    da Costa, Andre Nogueira
    [J]. BIOANALYSIS, 2016, 8 (23) : 2497 - 2518
  • [10] Circulating exosomal miRNAs as potential biomarker in liposarcoma
    Casadei, Lucia
    Creighton, Chad
    Batte, Kara
    Chelouche-Lev, Dina
    Croce, Carlo M.
    Pollock, Raphael E.
    [J]. CANCER RESEARCH, 2016, 76